Biotech

Aeolus to Present at the Lazard Capital Markets 8th Annual Healthcare Conference

MISSION VIEJO, CA: MISSION VIEJO, CA -- (Marketwire) -- 11/09/11 -- (OTCQB: AOLS) (PINKSHEETS: AOLS), a biotechnology company leveraging significant government funding to develop a platform of novel compounds in oncol ...

Functional Technologies Enters Evaluation Agreement With Significant European Confectionary Producer, Adding to Other Collaborative Activities

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 11/09/11 -- Functional Technologies Corp. (TSX VENTURE: FEB) (the "Company") is pleased to announce it has signed an agreement enabling an un ...

Alethia Biotherapeutics Announces Promising In Vivo Results for its EMT Inhibitor AB-16B5 and Issuance of a Patent for the Role of Secreted Clusterin in EMT

MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwire) -- 11/09/11 -- Alethia Biotherapeutics Inc., a privately held pre-clinical stage biotechnology company, announced today the issuance of US patent number 8,044,199 en ...

Allon Therapeutics Releases Q3 Operating Results and Provides Corporate Update

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 11/08/11 -- (TSX: NPC) today announced its unaudited operating results for the three and nine month periods ended September 30, 2011. Allon also said t ...

Dynavax Announces Exercise in Full of Overallotment Option and Completion of Public Offering of Common Stock

BERKELEY, CA: $64.5 Million in Net Proceeds ...

First Research Results of Angiomax(R) (Bivalirudin) Versus Heparin in Transcatheter Aortic Valve Interventions Reported at TCT

SAN FRANCISCO, CA: The Medicines Company Plans More Research in Emerging Field of Catheter-Based Valve Procedures ...

Concerned Shareholders Receive Majority Support for Changes to Helix Board and Calls on Board to Maintain Ordinary Course Business Activities Until Changes Are Effective

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwire) -- 11/08/11 -- A group of concerned shareholders ("Concerned Shareholders") of Helix BioPharma Corp. ("Helix"), led by Mr. Zbigniew Lobacz, a sig ...

SOHM Receives (CPR) Certificate of Product Registration in the Philippines

BUENA PARK, CA: SOHM Receives Two Product Registration Approvals for Its Anti Hypertension and Analgesic Pharmaceuticals Product Sales in the Philippines ...

Corcept Therapeutics Announces Third Quarter Results and Corporate and Development Update

MENLO PARK, CA: MENLO PARK, CA -- (Marketwire) -- 11/07/11 -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the ...

Arch Biopartners Engages Intertek Cantox to Devise Drug Development Plan for Lead Cancer Compound

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwire) -- 11/07/11 -- Arch Biopartners Inc ("Arch" or the "Company")(CNSX: ACH)(OTC: FOIFF) today announced it has engaged Intertek Cantox ("Cantox ...